Literature DB >> 15110322

Renal glucosuria due to SGLT2 mutations.

Robert Kleta1, Caroline Stuart, Fred A Gill, William A Gahl.   

Abstract

Isolated renal glucosuria results from mutations in SGLT2, which codes for an active transporter specific for d-glucose and expressed in the luminal membrane of the renal proximal tubule. In affected individuals, glucosuria leads to pursuit of hyperglycemia to exclude defects in glucose metabolism, and to investigation of renal proximal tubular function to exclude renal Fanconi syndrome. Here we present clinical and molecular data regarding a 19-year-old woman with isolated glucosuria. She was compound heterozygous for two SGLT2 mutations, i.e., a new missense mutation, T200K, and a known missense mutation, N654S.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110322     DOI: 10.1016/j.ymgme.2004.01.018

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  17 in total

1.  Familial renal glucosuria: a clinicogenetic study of 23 additional cases.

Authors:  HyunKyung Lee; Kyoung Hee Han; Hye Won Park; Jae Il Shin; Chan Jong Kim; Mee Kyung Namgung; Kee Hyuck Kim; Ja Wook Koo; Woo Young Chung; Dae-Yeol Lee; Su-Yung Kim; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2012-07       Impact factor: 3.714

2.  Glucosuria Is Not Always Due to Diabetes.

Authors:  Meghan Lewis; Bhagwan Dass
Journal:  Fed Pract       Date:  2021-02

Review 3.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

Review 4.  Salt-Losing Tubulopathies in Children: What's New, What's Controversial?

Authors:  Robert Kleta; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2017-12-13       Impact factor: 10.121

5.  SGLT2 mediates glucose reabsorption in the early proximal tubule.

Authors:  Volker Vallon; Kenneth A Platt; Robyn Cunard; Jana Schroth; Jean Whaley; Scott C Thomson; Hermann Koepsell; Timo Rieg
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

6.  Abnormal expression and dysfunction of novel SGLT2 mutations identified in familial renal glucosuria patients.

Authors:  Lei Yu; Ji-Cheng Lv; Xu-jie Zhou; Li Zhu; Ping Hou; Hong Zhang
Journal:  Hum Genet       Date:  2010-12-17       Impact factor: 4.132

7.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

8.  High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model.

Authors:  Xinlu Pan; Mysore K Phanish; Deborah L Baines; Mark E C Dockrell
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

9.  Clinical and genetic analysis in a patient with primary renal glucosuria: Identification of a novel mutation in the SLC5A2 gene.

Authors:  Yong-Wha Lee
Journal:  Exp Ther Med       Date:  2013-10-04       Impact factor: 2.447

10.  Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study.

Authors:  Kohei Kaku; Hirotaka Watada; Yasuhiko Iwamoto; Kazunori Utsunomiya; Yasuo Terauchi; Kazuyuki Tobe; Yukio Tanizawa; Eiichi Araki; Masamichi Ueda; Hideki Suganami; Daisuke Watanabe
Journal:  Cardiovasc Diabetol       Date:  2014-03-28       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.